» Articles » PMID: 2959408

Cellular Immunity Abnormalities in Patients with Recurrent Bell's Palsy

Overview
Date 1987 Aug 1
PMID 2959408
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Recurrent Bell's palsy is a rare form of facial paralysis. To investigate the role which cellular immunity plays in the aetiology of recurrent Bell's palsy, we evaluated a series of such patients using a laboratory test specially formulated to test the cellular immune system. We measured T-lymphocyte and T-lymphocyte subsets in the peripheral blood of 10 recurrent Bell's palsy patients and in 30 healthy volunteers. T-lymphocytes and T-lymphocyte subsets were reduced significantly in the patients, but the T-helper: T-cytotoxic ratio was normal. Cellular immunity abnormalities were therefore found in the peripheral blood of patients with recurrent Bell's palsy, supporting the concept that this is an immunomediated demyelinating disease.

Citing Articles

Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022.

Yoon D, Jung K, Kim J, Ko H, Yoon B, Shin J Emerg Infect Dis. 2024; 30(11):2313-2322.

PMID: 39378869 PMC: 11521192. DOI: 10.3201/eid3011.240610.


Monocyte to high-density lipoprotein ratio as a novel-potential biomarker for predicting prognosis of Bell's palsy.

Jin F, Yu E, Chen J, Zhou W, Cai H, Hu J Eur Arch Otorhinolaryngol. 2023; 281(5):2293-2301.

PMID: 38015248 DOI: 10.1007/s00405-023-08340-y.


Increased risk of cancer after Bell's palsy: a 5-year follow-up study.

Sheu J, Keller J, Lin H J Neurooncol. 2012; 110(2):215-20.

PMID: 22890970 DOI: 10.1007/s11060-012-0954-9.